Results 161 to 166 of about 5,794 (166)

LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design

Journal of Clinical Lipidology, 2016
Lukas Makris, Zahi A Fayad
exaly  

Analysis of LDL Receptor Gene Mutations in Italian Patients With Homozygous Familial Hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
Stefano Bertolini, S Calandra, M Ghisellini   +2 more
exaly  

Review of the long-term safety of lomitapide: a microsomal triglycerides transfer protein inhibitor for treating homozygous familial hypercholesterolemia

Expert Opinion on Drug Safety, 2019
Daniel Gaudet, Diane Brisson, Etienne Khoury   +2 more
exaly  

Patient with homozygous familial hypercholesterolemia

Atherosclerosis
Luka Prgomet, Matija Filipin, Ana Marija Andelic, Marieta Alagic, Kristina Paponja Mihanovic, Dunja Leskovar Lemesic, Drazen Perica, Nediljko Sucur, Željko Reiner, Bojan Jelaković, Ivan Pecin   +10 more
openaire   +1 more source

LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes

Circulation
Marina Cuchel, Santos Rd Santos R
exaly  

TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

2015
MARTIN ROBERT L, MCWHERTER CHARLES A, O'MARA PATRICK J   +2 more
openaire   +2 more sources